"Senate plans confirmation hearing for FDA head"
This article was originally published in Clinica
The US Senate's confirmation hearing for President Clinton's nominee to become the next FDA commissioner, Dr Jane Henney, is tentatively scheduled for September 1. Senator James Jeffords has sent Dr Henney a 26-page letter questioning her on her views on virtually every controversial issue faced by the FDA in recent years and her intentions if confirmed as commissioner. Most of the 140 questions concern the implementation of the Food and Drug Administration Modernization Act, approved last year. Senator Jeffords chairs the Senate Labor and Human Resources Committee which will hold the hearing. He said the questions would "serve as an early indicator" of what Dr Henney can expect to face at the hearing itself. She was asked to respond by August 20.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.